Pharmaceutical trademarks
Substantive legislative changes have
opened the door to the parallel
importation of pharmaceuticals in Israel.
Parallel importation cannot be prohibited,
unless the goods undergo substantial
changes such that they can no longer be
attributed to the mark owner.
To read more
Register for free for limited access
Register for free to receive our newsletter, view leading trademark professionals in WTR 1000 and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Subscribe now
Already have access? Login below
